Anaesthetic Products
- Experience and Competence

Making the right choice can be so easy.

The benefits for your patients: effective and generally easily tolerated products for local pain control.

3M ESPE offers you a choice of effective, generally easily tolerated local anaesthetics:

1. Ubistesin™ forte 1/200 000 solution for injection – for routine-type interventions.
2. Ubistesin™ forte 1/100 000 solution for injection – for more complex interventions requiring prolonged anaesthesia.
3. Xylestesin-A 1/ 80 000 solution for injection - for routine-type interventions

The benefits for your practice: an ingenious packaging system.

1. Cylindrical glass ampoules with inner coating of silicon.

• Smooth, gentle, controlled injection.
• Smoother gliding of the stopper.
• Less force required for injection and, more importantly, less initial resistance.

2. Safety foil instead of direct pressure on the glass.

• Protection from of splinters if the ampoule breaks (comparable to the laminated glass used in car windshields).
• Especially important for intraligamental anaesthesia, where particularly high stresses are applied.

3. Packaged in a solid metal storage tin with a padded interior.

• Protection against damage during shipping.
• Easy to remove.
• Simple to store neatly.
• Simple and ecological recycling.

Pluraject™ 2

Aspiration syringe for cylindrical glass ampoules with perforated stoppers.

• Easy handling
• Good aspiration
• Innovative square head reduces malfunction and wear

Ubistesin™ forte 1/200 000 – for routine-type interventions.

• Contains 4% Articaine with Adrenaline 1/200 000 as a vasoconstrictor.
• Contains only Sulphite as a stabilizer.
• Suitable for adults and children over the age of 4 years.
• Average duration of action: 45 minutes, with an onset period of 1–3 minutes.

Ubistesin™ forte 1/100 000 – for more complex interventions requiring prolonged anaesthesia.

• Contains 4% Articaine and Adrenaline 1/100 000 as a vasoconstrictor.
• Contains only Sulphite as a stabilizer.
• Suitable for adults and children over the age of 4 years.
• Average duration of action: 75 minutes, with an onset period of 1–3 minutes.

Xylestesin™- A

For routine-type interventions

• Contains 2% lidocaine with epinephrine 1/80000 as a vasoconstrictor
• Contains only sulfite as a stabilizer (max 0.31 mg)
• Suitable for adults and children
• Average duration of action: 30 – 60 minutes pulpal anesthesia and 120 – 180 minutes soft tissue anesthesia; onset period of 1–3 minutes
• Recommended maximum dose: 7 mg/kg body weight (500 mg for a 70 kg patient) for healthy adults; due to the addition of epinephrine 1/80000 the maximum dose of 20 ml of XylestesinTM- A (11.5 cartridges) must not be exceeded.